Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, Non-P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Mutat Res1
Search Results
Sort by
- BookC. Laird Birmingham, Janet Treasure.Summary: Now in its third edition, the Medical Management of Eating Disorders is the definitive text on the diagnosis and general management of patients with anorexia nervosa, bulimia nervosa, binge eating disorder and other related eating disorders. Providing up-to-date information and research on world-class treatments, this book helps health care professionals understand how to treat eating disorders and other subsequent medical complications that arise as a result of the patient's disorder. Each chapter begins with 'Study Questions' to focus the reader and put the relevant information into perspective, and concludes with 'Implications for Health Care Professionals' to summarise the key learnings of the chapter. 'Patient Information' sections are also included to give examples of how the topics covered can be presented to patients and families. This text is essential reading for all health care professionals involved in the care and management of patients with eating disorders.Digital Access Cambridge 2019
- ArticleLarimer FW, Ramey DW, Lijinsky W, Epler JL.Mutat Res. 1978 May;57(2):155-61.N-Nitrosopiperidine (NP) and a number of methylated derivatives were examined for mutagenicity in Saccharomyces cerevisiae. NP, 2-methyl-NP, 3-methyl-NP, 4-methyl-NP and 3,5-dimethyl-NP were mutagens when metabolic activation (rat-liver microsomes) was provided. 2,6-Dimethyl-NP was not a mutagen. The NPs giving a positive response stimulated forward mutation to canavanine resistance (CAN1 leads to can1) and reversion of the his1-7 missense marker. Neither locus revertants nor suppressors of the lys1-1 ochre marker were induced, nor were revertants of the putative frameshift hom3-10.